Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ultragenyx Pharmaceutical

39.30
+0.33000.85%
Post-market: 39.300.00000.00%16:07 EDT
Volume:1.04M
Turnover:41.32M
Market Cap:3.69B
PE:-6.25
High:40.13
Open:39.20
Low:39.18
Close:38.97
Loading ...
Jun 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
May 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Major Issues Report

Form 8-K - Current report
May 05, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 23, 2023

Major Issues Report

8-K - Current report
Mar 14, 2023

Major Issues Report

8-K - Current report
Feb 17, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 16, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2023

Major Issues Report

8-K - Current report